BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1 AND Diagnosis
10 results:

  • 1. Hypoxia-associated genetic signature in ovarian steroid cell tumor NOS.
    Chao A; Huang HJ; Lin CY; Lee CH; Lin CH; Chao AS; Lai CH; Chang TC; Wu KY; Wu RC
    Endocr Relat Cancer; 2023 Nov; 30(11):. PubMed ID: 37655726
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Disclosure of genetic risk to dating partners among young adults with von Hippel-Lindau disease.
    Bond E; Yashar B; Else T; Osborne J; Marvin M
    Fam Cancer; 2023 Apr; 22(2):203-215. PubMed ID: 35984582
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Imaging diagnosis of Von Hippel-Lindau Syndrome.
    Xu N; Duan W; Zhang R; Yang B
    J Craniofac Surg; 2019 Oct; 30(7):e674-e677. PubMed ID: 31574790
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ovarian Steroid Cell Tumor in an Adolescent With Von Hippel-Lindau Syndrome: A Case Report and Review of the Literature.
    Marques A; Portugal R
    Int J Gynecol Pathol; 2020 Sep; 39(5):473-477. PubMed ID: 31433374
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Combination of Sonographic Morphology Score and Tumor Markers for Detecting Postoperative Recurrent Pelvic ovarian Carcinoma: Compared With MRI Assessment.
    Shen ZY; Shen AJ; Yang SL; Wu MF
    Ultrasound Q; 2019 Mar; 35(1):45-53. PubMed ID: 30672869
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Moray micro forceps biopsy improves the diagnosis of specific pancreatic cysts.
    Zhang ML; Arpin RN; Brugge WR; Forcione DG; Basar O; Pitman MB
    Cancer Cytopathol; 2018 Jun; 126(6):414-420. PubMed ID: 29660844
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Uptake of prenatal diagnostic testing for retinoblastoma compared to other hereditary cancer syndromes in the Netherlands.
    Dommering CJ; Henneman L; van der Hout AH; Jonker MA; Tops CM; van den Ouweland AM; van der Luijt RB; Mensenkamp AR; Hogervorst FB; Redeker EJ; de Die-Smulders CE; Moll AC; Meijers-Heijboer H
    Fam Cancer; 2017 Apr; 16(2):271-277. PubMed ID: 27826806
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Immunohistochemical detection of the von Hippel-Lindau gene product (pvhl) in human tissues and tumors: a useful marker for metastatic renal cell carcinoma and clear cell carcinoma of the ovary and uterus.
    Lin F; Shi J; Liu H; Zhang J; Zhang PL; Wang HL; Yang XJ; Schuerch C
    Am J Clin Pathol; 2008 Apr; 129(4):592-605. PubMed ID: 18343787
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Detection of loss of heterozygosity at chromosome 3p25-26 in primary and metastatic ovarian clear-cell carcinoma: utilization of microdissection and polymerase chain reaction in archival tissues.
    Simsir A; Palacios D; Linehan WM; Merino MJ; Abati A
    Diagn Cytopathol; 2001 May; 24(5):328-32. PubMed ID: 11335962
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.